Cigna Group (NYSE:CI) Announces Quarterly Earnings Results

Cigna Group (NYSE:CI) released its quarterly earnings data on Thursday. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.57 by $0.22, Zacks reports. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.89 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period last year, the business posted $6.74 EPS. Cigna Group updated its FY 2026 guidance to 30.350- EPS.

Here are the key takeaways from Cigna Group’s conference call:

• Strong Q1 results — total revenues of $68.5 billion and adjusted EPS of $7.79; management raised full‑year adjusted EPS guidance to at least $30.35, signaling confidence in execution and outlook.
• Evernorth Specialty & Care Services outperformed — pre‑tax adjusted earnings rose ~20% driven by specialty volume growth, higher biosimilar/specialty‑generic adoption, and contribution from the Shields investment.
• PBS transition and renewals weighed on near‑term results — Pharmacy Benefit Services pre‑tax adjusted earnings declined ~28% (about a $150 million year‑over‑year headwind) due to large client renewals and investments to build the rebate‑free Signature model.
• Portfolio shaping announced — Cigna will exit the individual exchange at year‑end and is exploring strategic alternatives for eviCore; management says these moves are proactive and not expected to be material to capital recapture.
• Leadership transition set for July 1 — Brian Evanko will become CEO (David Cordani to Executive Chair) with an emphasized focus on data, AI, affordability, and personalization as strategic priorities.

Cigna Group Stock Down 0.6%

NYSE CI traded down $1.74 during midday trading on Thursday, hitting $290.58. 2,412,433 shares of the company traded hands, compared to its average volume of 1,339,993. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The company has a market cap of $76.58 billion, a PE ratio of 13.10, a price-to-earnings-growth ratio of 1.01 and a beta of 0.26. The company’s 50-day simple moving average is $274.24 and its 200-day simple moving average is $276.84. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is 28.13%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Royal Bank Of Canada reduced their price objective on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a report on Friday, February 6th. Robert W. Baird reduced their price objective on Cigna Group from $315.00 to $306.00 and set an “outperform” rating on the stock in a report on Wednesday, April 15th. TD Cowen raised their price objective on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, February 9th. UBS Group restated a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a report on Monday, February 9th. Finally, Truist Financial raised their price objective on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, Cigna Group has an average rating of “Moderate Buy” and an average price target of $332.47.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by company insiders.

Institutional Trading of Cigna Group

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Compound Planning Inc. lifted its holdings in shares of Cigna Group by 2.7% during the 4th quarter. Compound Planning Inc. now owns 1,944 shares of the health services provider’s stock valued at $535,000 after purchasing an additional 51 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Cigna Group by 27.4% during the 4th quarter. Invesco Ltd. now owns 2,421,775 shares of the health services provider’s stock valued at $666,545,000 after purchasing an additional 521,273 shares during the last quarter. Mercer Global Advisors Inc. ADV lifted its holdings in shares of Cigna Group by 8.3% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 47,873 shares of the health services provider’s stock valued at $13,176,000 after purchasing an additional 3,654 shares during the last quarter. Virtue Capital Management LLC purchased a new stake in shares of Cigna Group during the 4th quarter valued at $272,000. Finally, Vident Advisory LLC grew its stake in shares of Cigna Group by 80.5% during the fourth quarter. Vident Advisory LLC now owns 16,210 shares of the health services provider’s stock worth $4,462,000 after acquiring an additional 7,230 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna beat Q1 earnings expectations and raised its FY‑2026 adjusted EPS outlook to at least $30.35, signaling stronger profitability than analysts expected. Cigna Q1 Earnings Beat Estimates
• Positive Sentiment: Evernorth (Cigna’s health services/pharmacy-benefit unit) showed double‑digit revenue growth and drove margin/operational strength in the quarter, helping offset pharmacy cost pressures. Cigna Revenue Rises on Evernorth Growth
• Positive Sentiment: Company press release and Reuters coverage confirm revenue beat (~$68.5B) and a slight upward tweak to the annual adjusted profit forecast — fundamentals support near‑term earnings visibility. Cigna Reports Strong Q1 & Raises Outlook
• Neutral Sentiment: Market commentary and bullish research notes (Substack summaries, analyst price targets) reiterate long‑term upside based on valuation and diversified businesses, but these are opinions rather than new catalysts. Is CI a Good Stock to Buy?
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act individual market in 2027, affecting roughly 369,000 members — a near‑term subscriber loss and political/regulatory risk that likely pressured the stock. Cigna to Exit ACA Market
• Negative Sentiment: Quiver/filings show large institutional reductions from some major managers in recent quarters, which could amplify selling pressure even after the beat. Quiver Quantitative CI Earnings & Holdings
• Negative Sentiment: Analysts and reports note rising pharmacy costs; while Evernorth grew revenue, higher PBM/pharmacy expense remains a margin risk to monitor. PBM/Pharmacy Cost Commentary

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.